ShannonC.KenneyMD
Infectious Disease • Madison, WIProfessor, Medicine, University of Wisconsin Medical School
Dr. Kenney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-0946Fax+1 608-263-9103
Education & Training
University of North Carolina HospitalsFellowship, Infectious Disease, 1985 - 1987- University of North Carolina HospitalsResidency, Pediatrics, 1979 - 1983
Yale School of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1985 - Present
WI State Medical License 2006 - 2025
NC State Medical License 1979 - 2016
MD State Medical License 1983 - 1986- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1995
Publications & Presentations
PubMed
- 178 citationsEpstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse ModelGregory K. Hong, Margaret L. Gulley, Wen Hai Feng, Henri Jacques Delecluse, Elizabeth Holley-Guthrie
Journal of Virology. 2005-11-15 - 39 citationsDifferentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.Dhananjay M. Nawandar, Makoto Ohashi, Reza Djavadian, Elizabeth A. Barlow, Kathleen R. Makielski
Journal of Virology. 2017-03-29 - 88 citationsEpstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines.Gregory K. Hong, P. Anil Kumar, Ling Wang, Blossom Damania, Margaret L. Gulley
Journal of Virology. 2005-11-15
Grant Support
- Regulation Of EBV Infection In Epithelial CellsNational Cancer Institute2007–2012
- Ebv-Based Strategies For Aids-Related MalignanciesNational Cancer Institute2007–2012
- Inhibiting The Survival And Proliferation Of Ebv-Associated Tumor CellsNational Cancer Institute2008–2011
- Effect Of Lytic EBV Replication Proteins On The Virus And Host CellNational Cancer Institute2007–2009
- EBV Pathogenesis In A New Mouse ModelNational Cancer Institute2007–2008
- Effect Of Lytic EBV Replication Proteins On The VirusNational Cancer Institute2005–2006
- Ebv-Based Strategies For Aids-Related MalignanciesNational Cancer Institute2003–2006
- Regulation Of EBV Infection In Epithelial CellsNational Cancer Institute1999–2006
- Cytotoxic Therapy/Induce/Lytic Ebv/Ebv-MalignancyNational Cancer Institute2003
- EBV Based Strategies For AIDS Related MalignanciesNational Cancer Institute1999–2002
- Viral Interactions With P53 In Human CancerNational Cancer Institute1995–1998
- Gene Therapy For AIDS Related CNS LymphomasNational Cancer Institute1995–1998
- Regulation Of The EBV BRLF1 And BZLF1 PromotersNational Cancer Institute1993–1997
- Dysregulation Of C-MYC By EBV In AIDS LymphomasNational Cancer Institute1992–1996
- Dysregulation Of C-MYC By EBV In AIDS LymphomasNational Cancer Institute1992
- NCI Clinical Investigator AwardNational Cancer Institute1987–1991
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
